Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, MO.
Department of Obstetrics and Gynecology, Washington University in St. Louis, St. Louis, MO.
Am J Obstet Gynecol. 2020 Sep;223(3):442.e1-442.e7. doi: 10.1016/j.ajog.2020.06.019. Epub 2020 Jun 15.
Diagnostic criteria for hypertensive disorders in pregnancy have historically been based on the American Heart Association and American College of Cardiology's definition of hypertension, previously defined as a blood pressure of ≥140/90 mm Hg. With the recent redefinition of hypertension, blood pressures of 130 to 139/80 to 89 mm Hg are now considered abnormal.
In this study, we aimed to test whether the new-onset blood pressure elevations of 130 to 139/80 to 89 mm Hg after 20 weeks of gestation in previously normotensive women are associated with increased risk for adverse pregnancy outcomes, specifically the development of hypertensive disorders in pregnancy.
We performed a retrospective cohort study at a single tertiary care center of all women who delivered singleton gestations after 20 weeks of gestation from January 01, 2014, to June 08, 2016. Normotensive patients were defined as having maximum blood pressure of <130/80 mm Hg before 20 weeks of gestation and no previous diagnosis of chronic hypertension. Patients who remained normotensive for the remainder of pregnancy were then compared with patients who developed new-onset blood pressure elevations of 130 to 139/80 to 89 mm Hg after 20 weeks of gestation before delivery admission. The primary outcome was the development of a hypertensive disorder in pregnancy at hospital admission or during delivery. Clinical outcomes were assessed using χ test and multivariable logistic regression.
Of the 2090 normotensive women from our cohort who were analyzed, 1318 (63.0%) remained normotensive for their entire antenatal course before delivery admission and 772 (37.0%) had new-onset blood pressure elevations between 130 and 139/80 and 89 mm Hg. Women with new-onset blood pressure elevations between 130 and 139/80 and 89 mm Hg after 20 weeks of gestation have a significantly increased risk for developing a hypertensive disorder in pregnancy at admission or during delivery (adjusted relative risk, 2.41; 95% confidence interval, 2.02-2.85) including an almost 3-fold increased risk for preeclampsia with severe features, even after adjusting for confounders. There were no differences in other secondary obstetrical outcomes.
Normotensive women with new-onset blood pressures elevations between 130 and 139/80 and 89 mm Hg after 20 weeks of gestation are more likely to experience hypertensive disorders in pregnancy and preeclampsia with severe features at or during their delivery hospitalization. These more modest blood pressure elevations may be an early indicator of disease and call into question our current blood pressure threshold for diagnosis of hypertensive disorders in pregnancy.
妊娠高血压疾病的诊断标准历来基于美国心脏协会和美国心脏病学会的高血压定义,此前定义为血压≥140/90mmHg。随着高血压的重新定义,现在将 130 至 139/80 至 89mmHg 的血压视为异常。
本研究旨在检验妊娠 20 周后新出现的 130 至 139/80 至 89mmHg 的血压升高是否与不良妊娠结局风险增加相关,特别是妊娠高血压疾病的发生。
我们在一家三级保健中心进行了一项回顾性队列研究,纳入了 2014 年 1 月 1 日至 2016 年 6 月 8 日期间妊娠 20 周后分娩的单胎妊娠的所有女性。正常血压患者定义为妊娠 20 周前的最大血压<130/80mmHg,且无慢性高血压既往诊断。然后,将在妊娠期间保持正常血压的患者与在分娩入院前妊娠 20 周后新出现的 130 至 139/80 至 89mmHg 的血压升高的患者进行比较。主要结局是入院或分娩时发生妊娠高血压疾病。使用 χ²检验和多变量逻辑回归评估临床结局。
在我们的队列中,有 2090 名正常血压的女性进行了分析,其中 1318 名(63.0%)在分娩入院前整个产前过程中保持正常血压,772 名(37.0%)在妊娠 20 周后出现 130 至 139/80 至 89mmHg 的血压升高。妊娠 20 周后新出现的 130 至 139/80 至 89mmHg 的血压升高的女性发生入院或分娩时妊娠高血压疾病的风险显著增加(调整后的相对风险,2.41;95%置信区间,2.02-2.85),包括子痫前期重度特征的风险几乎增加 3 倍,即使在调整混杂因素后也是如此。其他次要产科结局无差异。
妊娠 20 周后新出现的 130 至 139/80 至 89mmHg 的血压升高的正常血压女性更有可能在分娩住院时经历妊娠高血压疾病和子痫前期重度特征。这些更为适度的血压升高可能是疾病的早期指标,并对我们目前用于诊断妊娠高血压疾病的血压阈值提出质疑。